There were 1,560 press releases posted in the last 24 hours and 429,084 in the last 365 days.

Medivation Announces Fourth Quarter and Year-End 2015 Financial Results Teleconference on February 25, 2016

/ -- SAN FRANCISCO, CA -- (Marketwired) -- 02/11/16 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss fourth quarter and year-end 2015 financial results and provide a general business update on February 25, 2016 at 4:30 p.m. Eastern Time. A press release for the fourth quarter and year-end of 2015 will be released after markets close on February 25, 2016.

Interested parties may listen to the live teleconference by calling 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals may access the live audio webcast by visiting:

About Medivation, Inc.
Medivation, Inc. is a biopharmaceutical company focused on the development and commercialization of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at

Rick Bierly
Chief Financial Officer
(415) 543-3470

Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900